格隆汇10月14日丨同源康医药-B(02410.HK)公告,公司董事会谨此建议对组织章程细则作出若干修订,以革新组织架构、加强维护公司中小股东权益、撤销公司监事会及订明董事会审计委员会须根据于2024年7月1日生效之经修订《中华人民共和国公司法》行使监事会的职权。
【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.